Single‐Cell Reveal GALNT7‐Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non‐Small Cell Lung Cancer

Jiadi Gan, Qian Zheng, Deng Liu, Ruichao Nie, Menglin Yao, Xiaolong Tang, Renjie Xu, Jinghong Xian, Wenjun Meng, Wenxin Luo, Dan Liu, Guiyi Ji · 2026

Read Single‐Cell Reveal GALNT7‐Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non‐Small Cell Lung Cancer by Jiadi Gan, Qian Zheng, Deng Liu, Ruichao Nie, Menglin Yao, Xiaolong Tang, Renjie Xu, Jinghong Xian, Wenjun Meng, Wenxin Luo, Dan Liu, Guiyi Ji (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13336806.txt.

Description

Jiadi Gan and colleagues hunt for why lung cancer immunotherapy fails in a 2026 multi-omics study. Tumors from patients on immune checkpoint therapy were profiled at single-cell, bulk, and spatial levels. A sugar-attaching enzyme, GALNT7, stood out: it was higher in patients who did not respond and sat mainly in cancer cells.

High GALNT7 matched low activity of ferroptosis, an iron-driven cell death route, while responders showed more of it. Silencing GALNT7 slowed growth, triggered that death route, and cut protective proteins SLC7A11 and GPX4. In mice, silencing shrank tumors, drew in killer T cells, and paired well with PD-1 blockade. A ferroptosis blocker undid the pairing gain, tying the effect to that death route.

Catalog record

CREATORJiadi Gan, Qian Zheng, Deng Liu, Ruichao Nie, Menglin Yao, Xiaolong Tang, Renjie Xu, Jinghong Xian, Wenjun Meng, Wenxin Luo, Dan Liu, Guiyi Ji
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE90762
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13336806

Browse the full library · About the Tower of Babel